The Food and Drug Administration (FDA) issued recommendations to aid manufacturers in developing seasonal and pandemic influenza vaccines. FDA’s goal is to expedite the development and availability of safe and effective vaccines needed to protect against influenza.
FDA considers the sale of unlicensed or unapproved influenza – related products as a potentially significant threat to the public health and is taking measures to protect consumers from fraudulent products that claim to prevent or treat seasonal or avian (bird) influenza in people.
The U.S. Food & Drug Administration (FDA) approved the use of Tamiflu (oseltamivir phosphate) for prevention (prophylaxis) of seasonal influenza (“flu”) in children 1 to 12 years of age who had close contact with an infected individual. This is the first drug approved for prevention of both influenza A and B in pediatric patients.
Sinusitis is inflammation of the linings of the sinuses that surround the nose. It is the inflammation of the mucous membranes of one or more of the sinuses. The sinuses are air-filled spaces in the skull behind the bones of the face and forehead that open up into the nasal cavity. They are lined with the mucous membrane and it produces a slimy secretion called as mucus to keep the nasal passageways moist and to trap dirt particles.
Following are the best health articles in September 2005, arranged as per viewed frequency:
The Food and Drug Administration (FDA) approved Fluarix, an influenza vaccine for adults that contains inactivated virus. Fluarix is approved to immunize adults 18 years of age and older against influenza virus types A and B contained in the vaccine. Influenza is also commonly called the flu.
Experiments in mice show that an antiviral drug currently used against annual influenza strains also can suppress the deadly influenza virus that has spread from birds to humans, killing dozens of people in Vietnam, Cambodia and Thailand since early 2004. This study, the first published report conducted on oseltamivir against the H5N1 influenza strain circulating in Vietnam, found that the drug, sold commercially as Tamiflu, dramatically boosted the survival rate of infected mice.
A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today. The novel antibiotic, PA-824, may shorten the time needed to treat tuberculosis (TB), a contagious disease that claims approximately two million lives worldwide each year. In partnership with the non-profit New York-based Global Alliance for TB Drug Development (TB Alliance), NIAID contributed to the drug candidate?s preclinical safety and efficacy testing in animal models. Now, a clinical trial to assess PA-824?s safety, sponsored by the TB Alliance, has opened at a medical clinic in Lincoln, NE.
Reproduction is one of the basic characteristics of a living organism. By this mode it not only maintains its own harmony but also helps in propagation of its own kind. In mammals, pregnancy is the hallmark of reproduction and in humans in particular a female takes 9 months to let the fetus grow in her womb so that it becomes viable and can live or can endure the circumstances outside the womb, of course still under parents love and care.
Homoeopathy (=homeopathy) is an alternative method of treatment, based on the nature?s Law of Cure, namely ?Like Cures Like?. A german scientist Dr. Samuel Hanhnemann in 1796 has been verified experimentally and clinically for 200 yrs discovered the truth of this law. Homoeopathy is the revolutionary, natural medical science. Homoeopathy is a gentle and effective system of medicine. The remedies are prepared from natural substances to precise standards and work by stimulating the body?s own healing power.